The Pharmacist Write Resources Hub

Categories

Categories
  • All
  • Patient Education and Medication Management (39)
  • Managed Care Pharmacy (32)
  • Technology and AI in Pharmacy (13)
  • Future of Pharmacy (12)
  • Opinion (9)
  • GLP1 Hub (8)
  • Healthcare Navigation and Insurance Literacy (5)
  • Reflective Intelligence (5)
  • Trading (2)
  • Biotech or Brick Series (1)
  • P3S (1)
What a Simple Drug Prior Authorization Policy Looks Like
From Extraction to Circulation: The Future of Billing Is Cooperative
Fear Is Not the Foe: Notes on Perceptual Pressure and the Soft Science of Sovereignty
The Platform Is the Train: How Algorithmic Anesthesia Is Rewiring Our Will
The Goodness Arbitrage Protocol (GAP): An Ethical Framework for Reflective Creation
Reflective Intelligence 101: How to Move from Resonance to Compellence with Calm, Clarity, and Conviction
Designing a Value-Based Formulary in 10 Steps
Switching from Semaglutide to Tirzepatide Dose Conversion Best Practices
How Long Can You Stay on Semaglutide for Weight Loss
Zepbound vs Semaglutide Safety Efficacy Coverage
Zepbound vs Mounjaro Which Is Better for Weight Loss
Is Zepbound the Same as Tirzepatide Understanding Brands and Generics
Zepbound vs Ozempic Key Differences for Weight Loss
How I Produced 100+ SEO/AIO-Optimized Articles Combining AI and Pharmacy Expertise
The P3S Framework: A Virtuous Cycle for Career Growth and Reflective Leadership
Pharmacy Benefit Management Consulting: What You Need to Know
Wegovy 1 Month Results: Setting Realistic Expectations
Does Wegovy Give You Energy? Separating Fact from Fiction
Knockout Gene-Inspired Prior Authorization Logic
How Pharmacy Benefit Analytics Improves Plan Efficiency & Cost Management
Tackling Wegovy Fatigue: Why It Happens & How to Cope
Drug Utilization Management 101: Rules, Tools & Best Practices
Unedited & Unfiltered: An Experience with Zepbound on a Weight Loss Journey
Wegovy Maintenance Dose After Goal Weight: What Patients Need to Know
At What Dose Does Wegovy Start Working? A Pharmacist’s Perspective
Semaglutide vs. Tirzepatide: Mechanisms, Differences, & Outcomes
Understanding GLP 1 & GLP1/GIP: The Superior Drug Class in Weight Management
Part 7: Gradual Governance Transfer – Shifting from Centralized PBMs to a Distributed, Multi-Stakeholder Model
Part 6: Applying Elinor Ostrom’s Framework – How Institutional Diversity Shapes Drug Coverage Node Enumeration
Part 5: Drug-Coverage Node Enumeration: Real-World Applications, Pilot Opportunities, and Future Outlook
Part 4: Building an Open Infrastructure for Node-Based Drug Coverage
Part 3: Building the Exhaustive Parameter Library: Enumerating All Coverage Options
Part 2: Introducing Enumerated Node-Based Drug Coverage: Redefining the Manufacturer–Payer Interface in Pharmacy Benefits
Part 1: The Origins of Drug Coverage Centralization – Why a New Model Is Needed
An Insurer-Less Pharmacy Ecosystem?
From P&T Committee to Exchange Forum: The Evolution of Drug Coverage Decision-Making
Reimagining The Claims Processing Partnership Structure: How Outsourcing Powers a Next-Gen PBM Alternative
Transparent Admin Fee vs. Spread Pricing: A Better Revenue Model for Pharmacy Services
Facing Manufacturer ‘Retribution’ Fears: How to Create a Safe Harbor for Direct Payer Deals
Decoupling Risk-Bearing from Pharmacy Benefits Managers: A Brief Overview for Self-Funded Employers
Formulary Contracting Exchanges: Bridging Manufacturers, Employers, and Insurers
P&T as a Service (P&TaaS): Bringing Clinical and Financial Clarity to Employers
Pharmacy Residencies: Advancing Your Career Path
Free Trade, Access, and Open Markets: PBM Lessons from Napoleon’s Free Port Vision
Adderall vs. Vyvanse: ADHD Treatment Options
Pharmacists’ Role in Managing Drug Shortages
Levemir vs Lantus – A Comparison of Long-Acting Insulins for Diabetes Management
Wearable Technology In Healthcare: the Pharmacist’s Role
Humalog vs. Novolog: Comparing Fast-Acting Insulins
Telepharmacy: Healthcare Medium with Unexpected Benefits